Cytotechnologists and on-site evaluation of adequacy

Jennifer A. Collins, Anna Novak, Syed Z Ali, Matthew T. Olson

Research output: Contribution to journalArticle

Abstract

While fine needle aspiration (FNA) is certainly not a new biopsy technique, recent developments in advanced imaging techniques, molecular testing, and targeted therapies have coincided with a rapid increase in the number of FNA procedures being performed. Concurrently, the demand for on-site evaluation of adequacy (OSEA) has also increased, outstripping the capacity of available cytopathologists at some institutions. Among the several alternatives to cytopathologist-performed OSEA, cytotechnologist-attended OSEA stands out because it preserves the representation of the pathology service at the time of the procedure. Herein, we review the current literature about OSEA and the necessity of cytotechnologists to expand access of this useful pathology service to a broader patient population. We also examine how cytotechnologists are likely to fit into the emerging practice of telecytology.

Original languageEnglish (US)
Pages (from-to)405-410
Number of pages6
JournalKorean Journal of Pathology
Volume47
Issue number5
DOIs
StatePublished - 2013

Fingerprint

Fine Needle Biopsy
Molecular Targeted Therapy
Pathology
Biopsy
Population

Keywords

  • Biopsy, fine needle aspiration
  • Cytotechnology
  • On-site evaluation of adequacy
  • Rapid on-site evaluation
  • Telecytology
  • Telepathology

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Cytotechnologists and on-site evaluation of adequacy. / Collins, Jennifer A.; Novak, Anna; Ali, Syed Z; Olson, Matthew T.

In: Korean Journal of Pathology, Vol. 47, No. 5, 2013, p. 405-410.

Research output: Contribution to journalArticle

Collins, Jennifer A. ; Novak, Anna ; Ali, Syed Z ; Olson, Matthew T. / Cytotechnologists and on-site evaluation of adequacy. In: Korean Journal of Pathology. 2013 ; Vol. 47, No. 5. pp. 405-410.
@article{d7efb1e673f74e799fffafd8dd2589ea,
title = "Cytotechnologists and on-site evaluation of adequacy",
abstract = "While fine needle aspiration (FNA) is certainly not a new biopsy technique, recent developments in advanced imaging techniques, molecular testing, and targeted therapies have coincided with a rapid increase in the number of FNA procedures being performed. Concurrently, the demand for on-site evaluation of adequacy (OSEA) has also increased, outstripping the capacity of available cytopathologists at some institutions. Among the several alternatives to cytopathologist-performed OSEA, cytotechnologist-attended OSEA stands out because it preserves the representation of the pathology service at the time of the procedure. Herein, we review the current literature about OSEA and the necessity of cytotechnologists to expand access of this useful pathology service to a broader patient population. We also examine how cytotechnologists are likely to fit into the emerging practice of telecytology.",
keywords = "Biopsy, fine needle aspiration, Cytotechnology, On-site evaluation of adequacy, Rapid on-site evaluation, Telecytology, Telepathology",
author = "Collins, {Jennifer A.} and Anna Novak and Ali, {Syed Z} and Olson, {Matthew T.}",
year = "2013",
doi = "10.4132/KoreanJPathol.2013.47.5.405",
language = "English (US)",
volume = "47",
pages = "405--410",
journal = "Journal of Pathology and Translational Medicine",
issn = "2383-7837",
publisher = "Korean Society of Pathologists",
number = "5",

}

TY - JOUR

T1 - Cytotechnologists and on-site evaluation of adequacy

AU - Collins, Jennifer A.

AU - Novak, Anna

AU - Ali, Syed Z

AU - Olson, Matthew T.

PY - 2013

Y1 - 2013

N2 - While fine needle aspiration (FNA) is certainly not a new biopsy technique, recent developments in advanced imaging techniques, molecular testing, and targeted therapies have coincided with a rapid increase in the number of FNA procedures being performed. Concurrently, the demand for on-site evaluation of adequacy (OSEA) has also increased, outstripping the capacity of available cytopathologists at some institutions. Among the several alternatives to cytopathologist-performed OSEA, cytotechnologist-attended OSEA stands out because it preserves the representation of the pathology service at the time of the procedure. Herein, we review the current literature about OSEA and the necessity of cytotechnologists to expand access of this useful pathology service to a broader patient population. We also examine how cytotechnologists are likely to fit into the emerging practice of telecytology.

AB - While fine needle aspiration (FNA) is certainly not a new biopsy technique, recent developments in advanced imaging techniques, molecular testing, and targeted therapies have coincided with a rapid increase in the number of FNA procedures being performed. Concurrently, the demand for on-site evaluation of adequacy (OSEA) has also increased, outstripping the capacity of available cytopathologists at some institutions. Among the several alternatives to cytopathologist-performed OSEA, cytotechnologist-attended OSEA stands out because it preserves the representation of the pathology service at the time of the procedure. Herein, we review the current literature about OSEA and the necessity of cytotechnologists to expand access of this useful pathology service to a broader patient population. We also examine how cytotechnologists are likely to fit into the emerging practice of telecytology.

KW - Biopsy, fine needle aspiration

KW - Cytotechnology

KW - On-site evaluation of adequacy

KW - Rapid on-site evaluation

KW - Telecytology

KW - Telepathology

UR - http://www.scopus.com/inward/record.url?scp=84887554696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887554696&partnerID=8YFLogxK

U2 - 10.4132/KoreanJPathol.2013.47.5.405

DO - 10.4132/KoreanJPathol.2013.47.5.405

M3 - Article

C2 - 24255627

AN - SCOPUS:84887554696

VL - 47

SP - 405

EP - 410

JO - Journal of Pathology and Translational Medicine

JF - Journal of Pathology and Translational Medicine

SN - 2383-7837

IS - 5

ER -